Mangoceuticals shares surge 10.92% intraday after launching program offering GLP-1 weight management drugs like Zepbound and Wegovy to expand telehealth access.

Mangoceuticals surged 10.92% intraday, as the company launched a program to directly deliver GLP-1 weight management drugs like Eli Lilly's Zepbound and Novo Nordisk's Wegovy via its MangoRx Direct and PeachesRx Direct platforms. The initiative aims to expand access to affordable obesity treatments and strengthens its telehealth presence in the weight loss drug market.